What will scientists do with $100 million to mass-produce genes in the lab?
Another chance to catch the most interesting, and important, articles from the previous week on MIT Technology Review.
Printing genomes on demand could mean custom-built organisms, difficult ethical questions, and profits for a handful of companies.
New approaches to generating crop varieties are making it hard for policymakers to know what to regulate.
Massive gene studies are letting biotechnology companies learn from nature, and imitate it.
The $121 million National Microbiome Initiative is meant to spur investigation into the mysterious functions of the micro?rganisms inside us.
It sounds crazy, and it is. A startup says it can use genetic engineering to change the color of animal coats.
New advances in biotechnology could keep your flowers in bloom longer.
An experimental treatment helps diabetic mice grow new blood vessels. It could offer new hope to people with vascular disease.
A gene therapy for an inherited immune disease completes a 27-year journey.